"TBSF" Human Immunoglobulin for Intravenous Use

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

normal immunoglobulin, Quantity: 60 g/L

Dostupné z:

CSL Behring Australia Pty Ltd

INN (Medzinárodný Name):

normal immunoglobulin

Forma lieku:

Injection, solution

Zloženie:

Excipient Ingredients: maltose

Spôsob podávania:

Intravenous

Počet v balení:

50mL, 200mL

Trieda:

Medicine Listed (Export Only)

Typ predpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikácie:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Prehľad produktov:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Stav Autorizácia:

Listed (Export Only)

Dátum Autorizácia:

2006-03-01